Takeda Pharmaceutical Company, Limited

Japan · Reporting entity ID 100000010889

Total reported 2019–2025

$4.67M

#734 of 2,960 reporting companies — 0% of all reported industry payments

$209K in general payments across 66 records, plus $4.46M in research funding across 16 records.

How it breaks down

General payments $209,144

Research funding $4,460,757

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.